Study of a triple cholesterol medicine combination in high-risk patients
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a cholesterol-lowering combination of three medicines: bempedoic acid, ezetimibe, and a statin (atorvastatin or rosuvastatin). It is for people with high cholesterol, especially those at high risk for heart problems, who need stronger treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- Your doctor considers you at high or very high risk for heart problems
- You have high cholesterol or a mixed type of high cholesterol
- You are starting or already taking a combination of bempedoic acid, ezetimibe, and either atorvastatin or rosuvastatin
- Your doctor confirms you have no medical reason to avoid these medicines
- You have a recent (within 5 years) LDL cholesterol test result before starting this combination
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a triple therapy pill (bempedoic acid, ezetimibe, and a high-intensity statin) in patients who have extensive plaque in their heart arteries but have never had a heart attack or stroke. It aims to see if this combination can further lower cholesterol and prevent future problems.
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.
This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study tests adding a newer cholesterol-lowering pill (bempedoic acid) to usual care for people who have been recently hospitalized for a heart event. It aims to see if the combination helps lower cholesterol better than standard medicines alone.
Hear when a new Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.